id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-N-0001-0007,FDA,FDA-2020-N-0001,"Scientific and Ethical Considerations for the Inclusion of Pregnant Women in
Clinical Trials; Public Meeting",Notice,Public Meetings,2020-12-21T05:00:00Z,2020,12,2020-12-21T05:00:00Z,,2020-12-21T13:28:07Z,2020-28069,0,0,09000064849ae945
FDA-2020-N-0001-0006,FDA,FDA-2020-N-0001,"Vaccines and Related Biological Products Advisory Committee; Notice
of Meeting",Notice,Announcement,2020-08-28T04:00:00Z,2020,8,2020-08-28T04:00:00Z,,2020-08-28T13:09:06Z,2020-18985,0,0,09000064848273b1
FDA-2020-N-0001-0005,FDA,FDA-2020-N-0001,Vaccines and Related Biological Products Advisory Committee; Notice of Meeting,Notice,Advisory Committee,2020-08-11T04:00:00Z,2020,8,2020-08-11T04:00:00Z,,2020-08-11T13:44:12Z,2020-17495,0,0,09000064847f06d3
FDA-2020-N-0001-0004,FDA,FDA-2020-N-0001,Preparation for International Cooperation on Cosmetics Regulation 14th Annual Meeting; Public Meeting; Cancellation,Notice,Meeting Postponement,2020-03-26T04:00:00Z,2020,3,2020-03-26T04:00:00Z,,2020-03-26T13:08:12Z,2020-06280,0,0,090000648446ae2c
FDA-2020-N-0001-0003,FDA,FDA-2020-N-0001,"March 10 Through April 30, 2020, Public Meetings; Postponement,
Cancellation, or Remote Only",Notice,Announcement,2020-03-19T04:00:00Z,2020,3,2020-03-19T04:00:00Z,,2020-03-19T13:12:24Z,2020-05743,0,0,09000064844540d7
FDA-2020-N-0001-0002,FDA,FDA-2020-N-0001,"Scientific and Ethical Considerations for the Inclusion of Pregnant Women in
Clinical Trials",Notice,Meeting,2020-03-11T04:00:00Z,2020,3,2020-03-11T04:00:00Z,,2020-03-11T12:56:54Z,2020-04990,0,0,090000648443771c
FDA-2020-N-0001-0001,FDA,FDA-2020-N-0001,Preparation for International Cooperation on Cosmetics Regulation Fourteenth Annual Meeting; Public Meeting,Notice,Public Meetings,2020-03-03T05:00:00Z,2020,3,2020-03-03T05:00:00Z,,2020-03-03T14:40:09Z,2020-04318,0,0,09000064843d8725